APA (7th ed.) Citation

Klein, U., Jauch, A., Hielscher, T., Hillengaß, J., Raab, M., Seckinger, A., . . . Neben, K. (2011). Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone. Cancer, 117(10), . https://doi.org/10.1002/cncr.25775

Chicago Style (17th ed.) Citation

Klein, Ulrike, et al. "Chromosomal Aberrations +1q21 and Del(17p13) Predict Survival in Patients with Recurrent Multiple Myeloma Treated with Lenalidomide and Dexamethasone." Cancer 117, no. 10 (2011). https://doi.org/10.1002/cncr.25775.

MLA (9th ed.) Citation

Klein, Ulrike, et al. "Chromosomal Aberrations +1q21 and Del(17p13) Predict Survival in Patients with Recurrent Multiple Myeloma Treated with Lenalidomide and Dexamethasone." Cancer, vol. 117, no. 10, 2011, https://doi.org/10.1002/cncr.25775.